A rizona S tudy of A ging and N eurodegenerative D isorders and B rain and B ody D onation P rogram

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · see citing works

Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium

McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,105 · see citing works

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961 · see citing works

Vascular dementia: Diagnostic criteria for research studies: Report of the NINDS‐AIREN International Workshop*

Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921 · see citing works

Inflammation and Alzheimer’s disease

Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514 · see citing works

Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease

(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336 · see citing works

Hearing loss and cognitive decline in older adults

Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017 · see citing works

Phases of Aβ-deposition in the human brain and its relevance for the development of AD

Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490 · see citing works

National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

Hyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.007 · Cited by 3,092 · see citing works

National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach

Montine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0910-3 · Cited by 2,992 · cited 7× · see citing works

Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Hixson, J., & Vernier, D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43176-1 · Cited by 2,933 · see citing works

Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859 · see citing works

Diagnostic Criteria for Parkinson Disease

Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822 · see citing works

The new stereological tools: Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis

Gundersen, H. J. G., Bagger, P. V., Bendtsen, T. F., Evans, S. M., Korbo, L., Marcussen, N., Møller, A., Nielsen, K. N., Nyengaard, J. R., Pakkenberg, B., et al. (1988) · Apmis · doi:10.1111/j.1699-0463.1988.tb00954.x · Cited by 2,480 · see citing works

Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature

Nelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050 · cited 1× · see citing works

Mixed brain pathologies account for most dementia cases in community-dwelling older persons

Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992 · see citing works

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

Naj, A. C., Jun, G., Beecham, G. W., Wang, L.-S., Vardarajan, B. N., Buros, J., Gallins, P. J., Buxbaum, J. D., Jarvik, G. P., Crane, P. K., et al. (2011) · Nature Genetics · doi:10.1038/ng.801 · Cited by 1,901 · see citing works

15-year longitudinal study of blood pressure and dementia

Skoog, I., Nilsson, L., Persson, G., Lernfelt, B., Landahl, S., Palmertz, B., Andreasson, L.-A., Odén, A., & Svanborg, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90608-x · Cited by 1,726 · see citing works

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

Kivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · BMJ · doi:10.1136/bmj.322.7300.1447 · Cited by 1,618 · see citing works

Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease

HYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542 · see citing works

Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease

Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530 · see citing works

Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010

Beach, T. G., Monsell, S. E., Phillips, L. E., & Kukull, W. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31824b211b · Cited by 1,103 · cited 2× · see citing works

A harmonized classification system for FTLD-TDP pathology

Mackenzie, I. R., Neumann, M., Baborie, A., Sampathu, D. M., du Plessis, D., Jaros, E., Perry, R. H., Trojanowski, J. Q., Mann, D. M. A., & Lee, V. M. ‐. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0845-8 · Cited by 1,013 · see citing works

Midlife blood pressure and dementia: the Honolulu–Asia aging study☆

Launer, L. J., Ross, G. W., Petrovitch, H., Masaki, K., Foley, D., White, L. R., & Havlik, R. J. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00096-8 · Cited by 1,008 · see citing works

Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria

Dickson, D. W., Braak, H., Duda, J. E., Duyckaerts, C., Gasser, T., Halliday, G. M., Hardy, J., Leverenz, J. B., Del Tredici, K., Wszolek, Z. K., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70238-8 · Cited by 972 · see citing works

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

Ikonomovic, M. D., Klunk, W. E., Abrahamson, E. E., Mathis, C. A., Price, J. C., Tsopelas, N. D., Lopresti, B. J., Ziolko, S., Bi, W., Paljug, W. R., et al. (2008) · Brain · doi:10.1093/brain/awn016 · Cited by 933 · see citing works

Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders

Arizona Parkinson’s Disease Consortium, Beach, T. G., Adler, C. H., Sue, L. I., Vedders, L., Lue, L., White III, C. L., Akiyama, H., Caviness, J. N., Shill, H. A., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0664-3 · Cited by 911 · see citing works

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study

Clark, C. M., Pontecorvo, M. J., Beach, T. G., Bedell, B. J., Coleman, R. E., Doraiswamy, P. M., Fleisher, A. S., Reiman, E. M., Sabbagh, M. N., Sadowsky, C. H., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70142-4 · Cited by 855 · see citing works

PGC-1 α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease

Zheng, B., Liao, Z., Locascio, J. J., Lesniak, K. A., Roderick, S. S., Watt, M. L., Eklund, A. C., Zhang‐James, Y., Kim, P. D., Hauser, M. A., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001059 · Cited by 854 · see citing works

Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias

West, M. J. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01362-9 · Cited by 814 · see citing works

Aggregation of vascular risk factors and risk of incident Alzheimer disease

Luchsinger, J. A., Reitz, C., Honig, L. S., Tang, M. X., Shea, S., & Mayeux, R. (2005) · Neurology · doi:10.1212/01.wnl.0000172914.08967.dc · Cited by 790 · see citing works

Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction

the Arizona Parkinson’s Disease Consortium, Beach, T. G., Adler, C. H., Lue, L., Sue, L. I., Bachalakuri, J., Henry-Watson, J., Sasse, J., Boyer, S., Shirohi, S., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0538-8 · Cited by 698 · see citing works

Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy

PSP Genetics Study Group, Höglinger, G. U., Melhem, N. M., Dickson, D. W., Sleiman, P. M. A., Wang, L.-S., Klei, L., Rademakers, R., de Silva, R., Litvan, I., et al. (2011) · Nature Genetics · doi:10.1038/ng.859 · Cited by 603 · see citing works

Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections

Braak, H., & Braak, E. (1991) · Brain Pathology · doi:10.1111/j.1750-3639.1991.tb00661.x · Cited by 598 · see citing works

Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons

Liang, W. S., Reiman, E. M., Valla, J., Dunckley, T., Beach, T. G., Grover, A., Niedzielko, T. L., Schneider, L. E., Mastroeni, D., Caselli, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709259105 · Cited by 585 · see citing works

Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions

Van Deerlin, V. M., Sleiman, P. M. A., Martinez-Lage, M., Chen-Plotkin, A., Wang, L.-S., Graff-Radford, N. R., Dickson, D. W., Rademakers, R., Boeve, B. F., Grossman, M., et al. (2010) · Nature Genetics · doi:10.1038/ng.536 · Cited by 579 · see citing works

Relative Quantification of Proteins in Human Cerebrospinal Fluids by MS/MS Using 6-Plex Isobaric Tags

Dayon, L., Hainard, A., Licker, V., Turck, N., Kuhn, K., Hochstrasser, D. F., Burkhard, P. R., & Sanchez, J. (2008) · Analytical Chemistry · doi:10.1021/ac702422x · Cited by 565 · see citing works

Low clinical diagnostic accuracy of early vs advanced Parkinson disease

Adler, C. H., Beach, T. G., Hentz, J. G., Shill, H. A., Caviness, J. N., Driver‐Dunckley, E. D., Sabbagh, M. N., Sue, L. I., Jacobson, S. A., Belden, C. M., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000641 · Cited by 503 · see citing works

GAB2 Alleles Modify Alzheimer's Risk in APOE ɛ4 Carriers

Reiman, E. M., Webster, J. A., Myers, A. J., Hardy, J., Dunckley, T., Zismann, V. L., Joshipura, K. D., Pearson, J. V., Hu-Lince, D., Huentelman, M. J., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.05.022 · Cited by 487 · see citing works

Clinico‐Neuropathological Correlation of Alzheimer's Disease in a Community‐Based Case Series

Lim, A., Tsuang, D. W., Kukull, W. A., Nochlin, D., Leverenz, J. B., McCormick, W. C., Bowen, J., Teri, L. L., Thompson, J. C., Peskind, E. R., et al. (1999) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1999.tb02571.x · Cited by 450 · see citing works

Involvement of Microglial Receptor for Advanced Glycation Endproducts (RAGE) in Alzheimer's Disease: Identification of a Cellular Activation Mechanism

Lue, L.-F., Walker, D. G., Brachova, L., Beach, T. G., Rogers, J., Schmidt, A. M., Stern, D. M., & Yan, S. D. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7732 · Cited by 439 · see citing works

Variants in the ATP-Binding Cassette Transporter (ABCA7), Apolipoprotein E ϵ4, and the Risk of Late-Onset Alzheimer Disease in African Americans

Reitz, C., Jun, G., Naj, A., Rajbhandary, R., Vardarajan, B. N., Wang, L.-S., Valladares, O., Lin, C.-F., Larson, E. B., Graff-Radford, N. R., et al. (2013) · JAMA · doi:10.1001/jama.2013.2973 · Cited by 431 · see citing works

Defining mild cognitive impairment in Parkinson's disease

Caviness, J. N., Driver‐Dunckley, E., Connor, D. J., Sabbagh, M. N., Hentz, J. G., Noble, B., Evidente, V. G. H., Shill, H. A., & Adler, C. H. (2007) · Movement Disorders · doi:10.1002/mds.21453 · Cited by 422 · see citing works

Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer's disease patients

Chouliaras, L., Mastroeni, D., Delvaux, E., Grover, A., Kenis, G., Hof, P. R., Steinbusch, H. W. M., Coleman, P. D., Rutten, B. P. F., & van den Hove, D. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.02.021 · Cited by 422 · see citing works

High total cholesterol levels in late life associated with a reduced risk of dementia

Mielke, M. M., Zandi, P. P., Sjögren, M., Gustafson, D., Östling, S., Steen, B., & Skoog, I. (2005) · Neurology · doi:10.1212/01.wnl.0000161870.78572.a5 · Cited by 411 · see citing works

Microinfarct Pathology, Dementia, and Cognitive Systems

Arvanitakis, Z., Leurgans, S. E., Barnes, L. L., Bennett, D. A., & Schneider, J. A. (2011) · Stroke · doi:10.1161/strokeaha.110.595082 · Cited by 404 · see citing works

Evidence for Seeding of β-Amyloid by Intracerebral Infusion of Alzheimer Brain Extracts in β-Amyloid Precursor Protein-Transgenic Mice

Kane, M. D., Lipinski, W. J., Callahan, M. J., Bian, F., Durham, R. A., Schwarz, R. D., Roher, A. E., & Walker, L. C. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-10-03606.2000 · Cited by 394 · see citing works

Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder

Boeve, B. F., Silber, M. H., Ferman, T. J., Lin, S. C., Benarroch, E. E., Schmeichel, A. M., Ahlskog, J. E., Caselli, R. J., Jacobson, S., Sabbagh, M., et al. (2013) · Sleep Medicine · doi:10.1016/j.sleep.2012.10.015 · Cited by 393 · see citing works

Epigenetic changes in Alzheimer's disease: Decrements in DNA methylation

Mastroeni, D., Grover, A., Delvaux, E., Whiteside, C. M., Coleman, P. D., & Rogers, J. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.12.005 · Cited by 386 · see citing works

Profiles of Extracellular miRNA in Cerebrospinal Fluid and Serum from Patients with Alzheimer's and Parkinson's Diseases Correlate with Disease Status and Features of Pathology

Burgos, K., Malenica, I., Metpally, R., Courtright, A., Rakela, B., Beach, T., Shill, H., Adler, C., Sabbagh, M., Villa, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094839 · Cited by 385 · see citing works

Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro

Lue, L., Rydel, R. E., Brigham, E. F., Yang, L., Hampel, H. J., Murphy, G. M., Brachova, L., Yan, S., Walker, D. G., Shen, Y., et al. (2001) · Glia · doi:10.1002/glia.1072 · Cited by 382 · see citing works

Human postmortem tissue: What quality markers matter?

Stan, A. D., Ghose, S., Gao, X.-M., Roberts, R. C., Lewis-Amezcua, K., Hatanpaa, K. J., & Tamminga, C. A. (2006) · Brain Research · doi:10.1016/j.brainres.2006.09.025 · Cited by 361 · see citing works

Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis

Whitcomb, D. C., LaRusch, J., Krasinskas, A. M., Klei, L., Smith, J. P., Brand, R. E., Neoptolemos, J. P., Lerch, M. M., Tector, M., Sandhu, B. S., et al. (2012) · Nature Genetics · doi:10.1038/ng.2466 · Cited by 352 · see citing works

The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins

Harrison, P. J., Heath, P. R., Eastwood, S. L., Burnet, P. W. J., McDonald, B., & Pearson, R. C. A. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12102-a · Cited by 342 · see citing works

Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain

Liang, W. S., Dunckley, T. L., Beach, T. G., Grover, A., Mastroeni, D., Walker, D. G., Caselli, R. J., Kukull, W. A., McKeel, D. W., Morris, J. C., et al. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00208.2006 · Cited by 342 · see citing works

Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain

Tomita, H., Vawter, M. P., Walsh, D. M., Evans, S. J., Choudary, P. V., Li, J., Overman, K. M., Atz, M. E., Myers, R. M., Jones, E. G., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.10.013 · Cited by 331 · see citing works

The Association of Weight Change in Alzheimer's Disease with Severity of Disease and Mortality: A Longitudinal Analysis

White, H., Pieper, C., & Schmader, K. (1998) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1998.tb04537.x · Cited by 323 · see citing works

Tissue pH as an indicator of mRNA preservation in human post-mortem brain

Kingsbury, A. E., Foster, O. J. F., Nisbet, A. P., Cairns, N. J., Bray, L., Eve, D. J., Lees, A. J., & MARSDEN, C. D. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(94)00219-5 · Cited by 320 · see citing works

Elevated Low-Density Lipoprotein in Alzheimer's Disease Correlates with Brain Aβ 1–42 Levels

Kuo, Y., Emmerling, M. R., Bisgaier, C. L., Essenburg, A. D., Lampert, H. C., Drumm, D. A., & Roher, A. E. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9652 · Cited by 312 · see citing works

Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set

Liang, W. S., Dunckley, T., Beach, T. G., Grover, A., Mastroeni, D., Ramsey, K., Caselli, R. J., Kukull, W. A., McKeel, D., Morris, J. C., et al. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00242.2007 · Cited by 309 · see citing works

Genetic Control of Human Brain Transcript Expression in Alzheimer Disease

Webster, J. A., Gibbs, J. R., Clarke, J., Ray, M., Zhang, W., Holmans, P., Rohrer, K., Zhao, A., Marlowe, L., Kaleem, M., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.03.011 · Cited by 304 · see citing works

PIB is a non-specific imaging marker of amyloid-beta (A ) peptide-related cerebral amyloidosis

Lockhart, A., Lamb, J. R., Osredkar, T., Sue, L. I., Joyce, J. N., Ye, L., Libri, V., Leppert, D., & Beach, T. G. (2007) · Brain · doi:10.1093/brain/awm191 · Cited by 302 · see citing works

Inflammation, A beta deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration.

Lue, L. F., Brachova, L., CIVIN, W. H., & Rogers, J. (1996) · PubMed · Cited by 299 · see citing works

Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI

Initiative, T. A. D. N., Shaw, L. M. J., Vanderstichele, H., Knapik-Czajka, M. E., Figurski, M., Coart, E., Blennow, K., Soares, H. D., Simon, A. J., Lewczuk, P., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0808-0 · Cited by 297 · see citing works

Biobanking: the foundation of personalized medicine

Hewitt, R. E. (2010) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32834161b8 · Cited by 291 · see citing works

Atherosclerosis and AD: Analysis of data from the US National Alzheimer’s Coordinating Center

Honig, L. S., Kukull, W., & Mayeux, R. (2005) · Neurology · doi:10.1212/01.wnl.0000150886.50187.30 · Cited by 284 · see citing works

Circle of Willis Atherosclerosis Is a Risk Factor for Sporadic Alzheimer’s Disease

Roher, A. E., Esh, C. L., Kokjohn, T. A., Kalback, W. M., Luehrs, D. C., Seward, J. D., Sue, L. I., & Beach, T. G. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000095973.42032.44 · Cited by 280 · see citing works

Increased Aβ Peptides and Reduced Cholesterol and Myelin Proteins Characterize White Matter Degeneration in Alzheimer's Disease

Roher, A. E., Weiss, N., Kokjohn, T. A., Kuo, Y.-M., Kalback, W., Anthony, J., Watson, D., Luehrs, D. C., Sue, L., Walker, D., et al. (2002) · Biochemistry · doi:10.1021/bi026173d · Cited by 279 · see citing works

Cortical and Leptomeningeal Cerebrovascular Amyloid and White Matter Pathology in Alzheimer’s Disease

Roher, A. E., Kuo, Y., Esh, C. L., Knebel, C., Weiss, N., Kalback, W. M., Luehrs, D. C., Childress, J., Beach, T. G., Weller, R. O., et al. (2003) · Molecular Medicine · doi:10.1007/bf03402043 · Cited by 275 · see citing works

Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: A potential mechanism leading to chronic inflammation

Walker, D. G., Dalsing-Hernandez, J. E., Campbell, N. A., & Lue, L. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.09.003 · Cited by 268 · see citing works

Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study

van Blitterswijk, M., DeJesus‐Hernandez, M., Niemantsverdriet, E., Murray, M. E., Heckman, M. G., Diehl, N. N., Brown, P. H., Baker, M., Finch, N. A., Bauer, P. O., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70210-2 · Cited by 266 · see citing works

Weight Loss Precedes Dementia in Community‐Dwelling Older Adults

Barrett-Connor, E. L., Edelstein, S. L., Corey‐Bloom, J., & Wiederholt, W. C. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb01362.x · Cited by 266 · see citing works

The Sun Health Research Institute Brain Donation Program: Description and Eexperience, 1987–2007

Beach, T., Sue, L., Walker, D., Roher, A., Lue, L., Vedders, L. J., Connor, D., Sabbagh, M., & Rogers, J. (2007) · Cell and Tissue Banking · doi:10.1007/s10561-008-9067-2 · Cited by 265 · see citing works

Enzyme Activities in Relation to pH and Lactate in Postmortem Brain in Alzheimer‐Type and Other <i>Dementias</i>

Yates, C. M., Butterworth, J., Tennant, M. C., & Gordon, A. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04948.x · Cited by 263 · see citing works

Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions

Li, J. Z., Vawter, M. P., Walsh, D. M., Tomita, H., Evans, S. J., Choudary, P. V., Lopez, J. F., Avelar, A., Shokoohi, V., Chung, T., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh065 · Cited by 261 · see citing works

Comparative Analysis of Amyloid-β Chemical Structure and Amyloid Plaque Morphology of Transgenic Mouse and Alzheimer's Disease Brains*

Kuo, Y.-M., Kokjohn, T., Beach, T., Sue, L., Brune, D., Lopez, J., Kalback, W., Abramowski, D., C. Sturchler-Pierrat, Staufenbiel, M., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007859200 · Cited by 259 · see citing works

Molecular and Cellular Characterization of the Membrane Attack Complex, C5b-9, in Alzheimer’s Disease

Webster, S. D., Lue, L., Brachova, L., Tenner, A. J., McGeer, P. L., Terai, K., Walker, D. G., Bradt, B. M., Cooper, N. R., & Rogers, J. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00042-0 · Cited by 258 · see citing works

Inflammation, Aβ deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration

Lue, L.-F., Brachova, L., Civin, H. W., & Rogers, J. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199655100-00008 · Cited by 246 · see citing works

<i>TMEM106B</i> regulates progranulin levels and the penetrance of FTLD in <i>GRN</i> mutation carriers

Finch, N., Carrasquillo, M. M., Baker, M., Rutherford, N. J., Coppola, G., DeJesus-Hernandez, M., Crook, R., Hunter, T., Ghidoni, R., Benussi, L., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31820a0e3b · Cited by 243 · see citing works

Psychological impact of genetic testing for Huntington's disease: an update of the literature

Meiser, B. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.5.574 · Cited by 243 · see citing works

Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases

Coppola, G., Chinnathambi, S., Lee, J. J., Dombroski, B. A., Baker, M. C., Soto-Ortolaza, A. I., Lee, S. E., Klein, E., Huang, A. Y., Sears, R., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds161 · Cited by 240 · see citing works

Biochemical and molecular studies using human autopsy brain tissue

Hynd, M. R., Lewohl, J. M., Scott, H. L., & Dodd, P. R. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01747.x · Cited by 237 · see citing works

Microglial chemotaxis, activation, and phagocytosis of amyloid β-peptide as linked phenomena in Alzheimer's disease

Rogers, J., & Lue, L.-F. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00040-7 · Cited by 236 · see citing works

Circle of Willis atherosclerosis: association with Alzheimer’s disease, neuritic plaques and neurofibrillary tangles

Beach, T. G., Wilson, J. R., Sue, L. I., Newell, A., Poston, M., Cisneros, R., Pandya, Y., Esh, C. L., Connor, D. J., Sabbagh, M. N., et al. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0136-y · Cited by 233 · see citing works

Amyloid-β Peptides Interact with Plasma Proteins and Erythrocytes: Implications for Their Quantitation in Plasma

Kuo, Y.-M., Kokjohn, T. A., Kalback, W., Luehrs, D., Galasko, D. R., Chevallier, N., Koo, E. H., Emmerling, M. R., & Roher, A. E. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2222 · Cited by 230 · see citing works

Weight Change in Alzheimer's Disease

White, H. K., Pieper, C. F., Schmader, K. E., & Fillenbaum, G. G. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb00912.x · Cited by 227 · see citing works

Extensive postmortem stability of RNA from rat and human brain

Johnson, S. A., Morgan, D. G., & Finch, C. E. (1986) · Journal of Neuroscience Research · doi:10.1002/jnr.490160123 · Cited by 224 · see citing works

Deficient Liver Biosynthesis of Docosahexaenoic Acid Correlates with Cognitive Impairment in Alzheimer's Disease

Astarita, G., Jung, K.-M., Berchtold, N. C., Nguyen, V. Q., Gillen, D. L., Head, E., Cotman, C. W., & Piomelli, D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012538 · Cited by 218 · see citing works

AN ANALYSIS OF FACTORS INFLUENCING MEASUREMENTS OF DOPAMINE, NORADRENALINE, GLUTAMATEDECARBOXYLASE AND CHOLINE ACETYLASE IN HUMAN POST-MORTEM BRAIN TISSUE

Spokes, E. G. (1979) · Brain · doi:10.1093/brain/102.2.333 · Cited by 216 · see citing works

Brain Expression Genome-Wide Association Study (eGWAS) Identifies Human Disease-Associated Variants

Zou, F., Chai, H. S., Younkin, C. S., Allen, M., Crook, J. E., Pankratz, V. S., Carrasquillo, M. M., Rowley, C. N., Nair, A., Middha, S., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002707 · Cited by 216 · see citing works

Quantitative EEG as a predictive biomarker for Parkinson disease dementia

Klassen, B. T., Hentz, J. G., Shill, H. A., Driver‐Dunckley, E. D., Evidente, V. G. H., Sabbagh, M. N., Adler, C. H., & Caviness, J. N. (2011) · Neurology · doi:10.1212/wnl.0b013e318224af8d · Cited by 215 · see citing works

Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C→T (Arg493X) mutation: an international initiative

Rademakers, R., Baker, M. C., Gass, J. M., Adamson, J. L., Huey, E. D., Momeni, P., Spina, S., Coppola, G., Karydas, A. M., Stewart, H. G., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70221-1 · Cited by 211 · see citing works

Quantifying mRNA in postmortem human brain: influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance

Preece, P., & Cairns, N. J. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(03)00337-1 · Cited by 206 · see citing works

Inflammatory changes parallel the early stages of Alzheimer disease

Parachikova, A., Agadjanyan, M. G., Cribbs, D. H., Blurton-Jones, M., Perreau, V., Rogers, J., Beach, T. G., & Cotman, C. W. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.08.014 · Cited by 203 · see citing works

Cortical Microinfarcts and Demyelination Significantly Affect Cognition in Brain Aging

Kövari, E., Gold, G., Herrmann, F. R., Canuto, A., Hof, P. R., Michel, J.-P., Bouras, C., & Giannakopoulos, P. (2004) · Stroke · doi:10.1161/01.str.0000110791.51378.4e · Cited by 202 · see citing works

Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects

Castaño, E. M., Roher, A. E., Esh, C. L., Kokjohn, T. A., & Beach, T. G. (2006) · Neurological Research · doi:10.1179/016164106x98035 · Cited by 201 · see citing works

THE PARADOX OF HIGH RISK OF STROKE IN POPULATION WITH LOW RISK OF CORONARY HEART DISEASE

REED, D. M. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115542 · Cited by 198 · see citing works

Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy

Arai, T., Ikeda, K., Akiyama, H., Shikamoto, Y., Tsuchiya, K., Yagishita, S., Beach, T. G., Rogers, J., Schwab, C., & McGeer, P. L. (2001) · Acta Neuropathologica · doi:10.1007/s004010000283 · Cited by 197 · see citing works

SORL1 Is Genetically Associated with Late-Onset Alzheimer’s Disease in Japanese, Koreans and Caucasians

Miyashita, A., Koike, A., Jun, G., Wang, L.-S., Takahashi, S., Matsubara, E., Kawarabayashi, T., Shoji, M., Tomita, N., Arai, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058618 · Cited by 196 · see citing works

Cerebral blood flow in Alzheimer’s disease

Roher, A., Debbins, J., Malek-Ahmadi, M., Chen, K.-W., Pipe, J., Maze, S., Belden, C. M., Maarouf, C., Thiyyagura, P., Mo, H., et al. (2012) · Vascular Health and Risk Management · doi:10.2147/vhrm.s34874 · Cited by 194 · see citing works

Pathologic findings in prospectively ascertained essential tremor subjects

Shill, H. A., Adler, C. H., Sabbagh, M. N., Connor, D. J., Caviness, J. N., Hentz, J. G., & Beach, T. G. (2008) · Neurology · doi:10.1212/01.wnl.0000310425.76205.02 · Cited by 194 · see citing works

Amyloid-β Peptide Remnants in AN-1792-Immunized Alzheimer's Disease Patients

Patton, R., Kalback, W. M., Esh, C. L., Kokjohn, T. A., Vickle, G. D. V., Luehrs, D. C., Kuo, Y., Lopez, J. C., Brune, D. C., Ferrer, I., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060269 · Cited by 192 · see citing works

Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain

Styren, S. D., Civin, W. H., & Rogers, J. (1990) · Experimental Neurology · doi:10.1016/0014-4886(90)90054-v · Cited by 191 · see citing works

Identification of extracellular miRNA in human cerebrospinal fluid by next-generation sequencing

Burgos, K., Javaherian, A., Bomprezzi, R., Ghaffari, L., Rhodes, S. N., Courtright-Lim, A., Tembe, W., Kim, S., Metpally, R. P. R., & Keuren‐Jensen, K. R. V. (2013) · RNA · doi:10.1261/rna.036863.112 · Cited by 190 · see citing works

Alzheimer's disease: striatal amyloid deposits and neurofibrillary changes.

Braak, H., & Braak, E. (1990) · PubMed · Cited by 189 · see citing works

Cyclooxygenase-1 in Human Alzheimer and Control Brain: Quantitative Analysis of Expression by Microglia and CA3 Hippocampal Neurons

Yermakova, A., Rollins, J., Callahan, L. M., Rogers, J., & O’Banion, M. K. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199911000-00003 · Cited by 187 · see citing works

The patients dying after long terminal phase have acidotic brains; implications for biochemical measurements on autopsy tissue

Hardy, J. A., Wester, P., Winblad, B., Gezelius, C., Bring, G., & Eriksson, A. (1985) · Journal of Neural Transmission · doi:10.1007/bf01251916 · Cited by 185 · see citing works

Parkinson’s disease is not associated with gastrointestinal myenteric ganglion neuron loss

Annerino, D. M., Arshad, S., Taylor, G. M., Adler, C., Beach, T., & Greene, J. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1040-2 · Cited by 185 · see citing works

High Levels of Circulating Aβ42 Are Sequestered by Plasma Proteins in Alzheimer's Disease

Kuo, Y., Emmerling, M. R., Lampert, H. C., Hempelman, S. R., Kokjohn, T. A., Woods, A. S., Cotter, R. J., & Roher, A. E. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0552 · Cited by 182 · see citing works

Quantitative Measurement of Intact Alpha-Synuclein Proteoforms from Post-Mortem Control and Parkinson's Disease Brain Tissue by Intact Protein Mass Spectrometry

Kellie, J. F., Higgs, R. E., Ryder, J. W., Major, A., Beach, T. G., Adler, C. H., Merchant, K., & Knierman, M. D. (2014) · Scientific Reports · doi:10.1038/srep05797 · Cited by 182 · cited 1× · see citing works

Evaluation of α-synuclein immunohistochemical methods used by invited experts

Beach, T. G., White, C. L., Hamilton, R. L., Duda, J. E., Iwatsubo, T., Dickson, D. W., Leverenz, J. B., Roncaroli, F., Buttini, M., Hladik, C. L., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0409-8 · Cited by 182 · see citing works

Gene expression changes by amyloid β peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes

Walker, D. G., Link, J., Lue, L., Dalsing-Hernandez, J. E., & Boyes, B. E. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0705377 · Cited by 180 · see citing works

Quantification of mRNA degradation as possible indicator of postmortem interval—a pilot study

Bauer, M., Gramlich, I., Polzin, S., & Patzelt, D. (2003) · Legal Medicine · doi:10.1016/j.legalmed.2003.08.001 · Cited by 179 · see citing works

Isolation, Chemical Characterization, and Quantitation of Aβ 3-Pyroglutamyl Peptide from Neuritic Plaques and Vascular Amyloid Deposits

Kuo, Y.-M., Emmerling, M. R., Woods, A. S., Cotter, R. J., & Roher, A. E. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7083 · Cited by 178 · see citing works

Gene expression correlates of neurofibrillary tangles in Alzheimer's disease

Dunckley, T., Beach, T. G., Ramsey, K. E., Grover, A., Mastroeni, D., Walker, D. G., LaFleur, B. J., Coon, K. D., Brown, K. M., Caselli, R., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.08.013 · Cited by 177 · see citing works

Peripheral clearance of amyloid β peptide by complement C3-dependent adherence to erythrocytes

Rogers, J., Li, R., Mastroeni, D., Grover, A., Leonard, B., Ahern, G., Cao, P., Kolody, H., Vedders, L., Kolb, W. P., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.043 · Cited by 175 · see citing works

Microglia Activation and Anti-inflammatory Regulation in Alzheimer’s Disease

Lue, L., Kuo, Y., Beach, T. G., & Walker, D. G. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8106-8 · Cited by 175 · see citing works

Alzheimerʼs Disease

Braak, H., & Braak, E. (1990) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199005000-00003 · Cited by 175 · see citing works

3‐hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis

LeWitt, P. A., Li, J., Lü, M., Beach, T. G., Adler, C. H., & Guo, L. (2013) · Movement Disorders · doi:10.1002/mds.25555 · Cited by 174 · see citing works

A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer's disease

Vallet, P. G., Guntern, R., Hof, P. R., Golaz, J., Delacourte, A., Robakis, N. K. R. K., & Bouras, C. (1992) · Acta Neuropathologica · doi:10.1007/bf00308476 · Cited by 170 · see citing works

Elevated Aβ42 in Skeletal Muscle of Alzheimer Disease Patients Suggests Peripheral Alterations of AβPP Metabolism

Kuo, Y.-M., Kokjohn, T. A., Watson, M. D., Woods, A. S., Cotter, R. J., Sue, L. I., Kalback, W. M., Emmerling, M. R., Beach, T. G., & Roher, A. E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64947-4 · Cited by 167 · see citing works

Modeling microglial activation in Alzheimer's disease with human postmortem microglial cultures

Lue, L. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00311-6 · Cited by 165 · see citing works

Estrogen Enhances Uptake of Amyloid β‐Protein by Microglia Derived from the Human Cortex

Li, R., Shen, Y., Yang, L., Lue, L., Finch, C. E., & Rogers, J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751447.x · Cited by 162 · see citing works

Concomitant pathologies among a spectrum of parkinsonian disorders

Dugger, B. N., Adler, C. H., Shill, H. A., Caviness, J. N., Jacobson, S. A., Driver‐Dunckley, E. D., & Beach, T. G. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.02.012 · Cited by 161 · see citing works

Effects of Antemortem and Postmortem Variables on Human Brain mRNA Quality: A BrainNet Europe Study

Durrenberger, P. F., Fernando, S., Kashefi, S. N., Ferrer, I., Hauw, J.-J., Seilhean, D., Smith, C., Walker, R., Al-Sarraj, S., Troakes, C., et al. (2010) · Journal of Neuropathology &amp; Experimental Neurology · doi:10.1097/nen.0b013e3181c7e32f · Cited by 161 · see citing works

Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease

Kalback, W. M., Esh, C. L., Castaño, E. M., Rahman, A., Kokjohn, T. A., Luehrs, D. C., Sue, L. I., Cisneros, R., Gerber, F., Richardson, C., et al. (2004) · Neurological Research · doi:10.1179/016164104225017668 · Cited by 160 · see citing works

Postmortem interval effect on RNA and gene expression in human brain tissue

Birdsill, A. C., Walker, D. G., Lue, L., Sue, L. I., & Beach, T. G. (2010) · Cell and Tissue Banking · doi:10.1007/s10561-010-9210-8 · Cited by 157 · see citing works

Alzheimer's disease: amyloid plaques in the cerebellum

Braak, H., Braak, E., Böhl, J., & Lang, W. (1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90197-4 · Cited by 157 · see citing works

Gene expression profiling of amyloid beta peptide-stimulated human post-mortem brain microglia

Walker, D. G. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00306-2 · Cited by 155 · see citing works

Alpha-Synuclein Pathology and Axonal Degeneration of the Peripheral Motor Nerves Innervating Pharyngeal Muscles in Parkinson Disease

Mu, L., Sobótka, S., Chen, J., Su, H., Sanders, I., Adler, C. H., Shill, H. A., Caviness, J. N., Samanta, J., & Beach, T. G. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182801cde · Cited by 155 · see citing works

Parkinson Disease Affects Peripheral Sensory Nerves in the Pharynx

Mu, L., Sobótka, S., Chen, J., Su, H., Sanders, I., Nyirenda, T. L., Adler, C. H., Shill, H. A., Caviness, J. N., Samanta, J., et al. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182965886 · Cited by 154 · see citing works

TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia

van Blitterswijk, M., Mullen, B., Nicholson, A. M., Bieniek, K. F., Heckman, M. G., Baker, M., DeJesus‐Hernandez, M., Finch, N. A., Brown, P. H., Murray, M. E., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-013-1240-4 · Cited by 154 · see citing works

Challenges of multimorbidity of the aging brain: a critical update

Jellinger, K. A., & Attems, J. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-014-1288-x · Cited by 154 · see citing works

The Cholinergic Deficit Coincides with Aβ Deposition at the Earliest Histopathologic Stages of Alzheimer Disease

Beach, T. G., Kuo, Y., Spiegel, K., Emmerling, M. R., Sue, L. I., Kokjohn, K., & Roher, A. E. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.4.308 · Cited by 153 · see citing works

Changes in Properties of Serine 129 Phosphorylated α-Synuclein with Progression of Lewy Type Histopathology in Human Brains

Walker, D., Lue, L., Adler, C., Shill, H. A., Caviness, J., Sabbagh, M., Akiyama, H., Serrano, G., Sue, L., & Beach, T. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.11.020 · Cited by 150 · see citing works

Altered Pharyngeal Muscles in Parkinson Disease

Mu, L., Sobótka, S., Chen, J., Su, H., Sanders, I., Adler, C. H., Shill, H. A., Caviness, J. N., Samanta, J., & Beach, T. G. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318258381b · Cited by 149 · see citing works

Amyloid and tau proteins in cortical brain biopsy and Alzheimer's disease

Leinonen, V., Koivisto, A. M., Savolainen, S., Rummukainen, J. K., Tamminen, J. N., Tillgren, T., Vainikka, S., Pyykkö, O. T., Mölsä, J. A. A., zu Fraunberg, M. V. U., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22100 · Cited by 149 · see citing works

The effects of progressive formaldehyde fixation on the preservation of tissue antigens

Leong, A. S.-Y., & Gilham, P. (1989) · Pathology · doi:10.3109/00313028909061071 · Cited by 146 · see citing works

Atherosclerosis of Cerebral Arteries in Alzheimer Disease

Roher, A. E., Esh, C. L., Rahman, A., Kokjohn, T. A., & Beach, T. G. (2004) · Stroke · doi:10.1161/01.str.0000143317.70478.b3 · Cited by 146 · see citing works

Rheumatic diseases in North America's indigenous peoples

PESCHKEN, C. A., & Esdaile, J. M. (1999) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(99)80003-1 · Cited by 145 · see citing works

Intracranial atherosclerosis as a contributing factor to Alzheimer's disease dementia

Roher, A. E., Tyas, S. L., Maarouf, C. L., Daugs, I. D., Kokjohn, T. A., Emmerling, M. R., Garami, Z. F., Bëlohlávek, M., Sabbagh, M. N., Sue, L. I., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.08.228 · Cited by 144 · see citing works

Incidental Lewy body disease: Clinical comparison to a control cohort

Adler, C. H., Connor, D. J., Hentz, J. G., Sabbagh, M. N., Caviness, J. N., Shill, H. A., Noble, B., & Beach, T. G. (2010) · Movement Disorders · doi:10.1002/mds.22971 · Cited by 143 · see citing works

Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects

Beach, T. G., Carew, J., Serrano, G. E., Adler, C. H., Shill, H. A., Sue, L. I., Sabbagh, M. N., Akiyama, H., & Cuenca, N. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.04.027 · Cited by 142 · see citing works

Multivariate analysis of RNA levels from postmortem human brains as measured by three different methods of RT-PCR

Johnston, N. L., Cerevnak, J., Shore, A. D., Torrey, E. F., & Yolken, R. H. (1997) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(97)00115-5 · Cited by 141 · see citing works

Alzheimer's disease: areal and laminar pathology in the occipital isocortex

Braak, H., Braak, E., & Kalus, P. (1989) · Acta Neuropathologica · doi:10.1007/bf00687251 · Cited by 140 · see citing works

Are Alzheimer Patients Healthier?

Wolf‐Klein, G. P., Silverstone, F. A., Brod, M. S., Levy, A. P., Foley, C. J., Termotto, V., & Breuer, J. (1988) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1988.tb01804.x · Cited by 140 · see citing works

Alzheimer's disease and the eye

Armstrong, R. A., & Syed, A. B. (1996) · Ophthalmic & physiological optics · doi:10.3921/joptom.2009.103 · Cited by 138 · see citing works

Transcranial Doppler ultrasound blood flow velocity and pulsatility index as systemic indicators for Alzheimer's disease

Roher, A. E., Garami, Z. F., Tyas, S. L., Maarouf, C. L., Kokjohn, T. A., Bëlohlávek, M., Vedders, L. J., Connor, D. J., Sabbagh, M. N., Beach, T. G., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.09.002 · Cited by 138 · see citing works

An Improved Approach to Prepare Human Brains for Research

Vonsattel, J. P., Aizawa, H., DiFiglia, M., McKee, A. C., MacDonald, M. E., Gusella, J. F., Landwehrmeyer, G. B., Bird, E. D., Richardson, E. P., & Hedley‐Whyte, E. T. (1995) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199501000-00006 · Cited by 134 · see citing works

Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer’s disease pathologies

Thompson, P. W., Ye, L., Morgenstern, J. L., Sue, L. I., Beach, T. G., Judd, D. J., Shipley, N. J., Libri, V., & Lockhart, A. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05996.x · Cited by 133 · see citing works

Submandibular gland needle biopsy for the diagnosis of Parkinson disease

Adler, C. H., Dugger, B. N., Hinni, M. L., Lott, D. G., Driver‐Dunckley, E. D., Hidalgo, J., Henry-Watson, J., Serrano, G. E., Sue, L. I., Nagel, T. H., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000204 · Cited by 132 · see citing works

Both early and late cognitive dysfunction affects the electroencephalogram in Parkinson's disease

Caviness, J. N., Hentz, J. G., Evidente, V. G. H., Driver‐Dunckley, E. D., Samanta, J., Mahant, P., Connor, D. J., Sabbagh, M. N., Shill, H. A., & Adler, C. H. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.01.003 · Cited by 130 · see citing works

Correlation of Amyloid PET Ligand Florbetapir F 18 Binding With Aβ Aggregation and Neuritic Plaque Deposition in Postmortem Brain Tissue

Choi, S., Schneider, J. A., Bennett, D. A., Beach, T. G., Bedell, B. J., Zehntner, S. P., Krautkramer, M. J., Kung, H. F., Skovronsky, D., Hefti, F. F., et al. (2011) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31821300bc · Cited by 129 · see citing works

Reduced striatal tyrosine hydroxylase in incidental Lewy body disease

Beach, T. G., Adler, C. H., Sue, L. I., Peirce, J. B., Bachalakuri, J., Dalsing-Hernandez, J. E., Lue, L. F., Caviness, J. N., Connor, D. J., Sabbagh, M. N., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-007-0313-7 · Cited by 128 · see citing works

Preventing Activation of Receptor for Advanced Glycation Endproducts in Alzheimers Disease

Lue, L.-F., Yan, S. D., Stern, D. F., & Walker, D. G. (2005) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007054038210 · Cited by 126 · see citing works

The influence of agonal status on some neurochemical activities of postmortem human brain tissue

Perry, E. K., Perry, R. H., & Tomlinson, B. E. (1982) · Neuroscience Letters · doi:10.1016/0304-3940(82)90334-2 · Cited by 125 · see citing works

Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer’s disease

Berchtold, N. C., Sabbagh, M. N., Beach, T. G., Kim, R. C., Cribbs, D. H., & Cotman, C. W. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.031 · Cited by 124 · see citing works

Estimating cerebral microinfarct burden from autopsy samples

Westover, M. B., Bianchi, M. T., Yang, C., Schneider, J. A., & Greenberg, S. M. (2013) · Neurology · doi:10.1212/wnl.0b013e31828c2f52 · Cited by 122 · see citing works

Irreversible dimerization/tetramerization and post-translational modifications inhibit proteolytic degradation of Aβ peptides of Alzheimer's disease

Kuo, Y.-M., Webster, S., Emmerling, M. R., De Lima, N., & Roher, A. E. (1998) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(98)00014-3 · Cited by 122 · see citing works

Post‐mortem stability of dopamine. glutamate decarboxylase and choline acetyltransferase in the mouse brain under conditions simulating the handling of human autopsy material

SPOKES, E. G. S., & Koch, D. (1978) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1978.tb12477.x · Cited by 121 · see citing works

Genetic and Clinical Features of Progranulin-Associated Frontotemporal Lobar Degeneration

Chen-Plotkin, A. S., Martinez-Lage, M., Sleiman, P. M. A., Hu, W., Greene, R., Wood, E. M., Bing, S., Grossman, M., Schellenberg, G. D., Hatanpaa, K. J., et al. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.53 · Cited by 120 · see citing works

Background and current status of postmortem imaging in Japan: Short history of “Autopsy imaging (Ai)”

Okuda, T., Shiotani, S., Sakamoto, N., et al. (2012) · Forensic Science International · doi:10.1016/j.forsciint.2012.03.010 · Cited by 116 · see citing works

Detection of complement alternative pathway mRNA and proteins in the Alzheimer’s disease brain

Strohmeyer, R., Shen, Y., & Rogers, J. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00149-2 · Cited by 114 · see citing works

Submandibular Gland Biopsy for the Diagnosis of Parkinson Disease

Beach, T. G., Adler, C. H., Dugger, B. N., Serrano, G. E., Hidalgo, J., Henry-Watson, J., Shill, H. A., Sue, L. I., Sabbagh, M. N., & Akiyama, H. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182805c72 · Cited by 114 · see citing works

A microarray study of post-mortem mRNA degradation in mouse brain tissue

Catts, V. S., Catts, S. V., Fernandez, H. R., Taylor, J. M., Coulson, E. J., & Lutze-Mann, L. H. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.04.017 · Cited by 113 · see citing works

Biological stability of mRNA isolated from human postmortem brain collections

Leonard, S. S., Logel, J., Luthman, D., Casanova, M. F., Kirch, D. G., & Freedman, R. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90174-c · Cited by 112 · see citing works

Chapter 7 Brain banking and the human hypothalamus — factors to match for, pitfalls and potentials

Ravid, R., van Zwieten, E. J., & Swaab, D. F. (1992) · Progress in brain research · doi:10.1016/s0079-6123(08)64565-3 · Cited by 111 · see citing works

Second nation-wide study of atherosclerosis in infants, children and young adults in Japan

Imakita, M., Yutani, C., Strong, J. P., Sakurai, I., Sumiyoshi, A., Watanabe, T., Mitsumata, M., Kusumi, Y., Katayama, S., Mano, M., et al. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00595-5 · Cited by 111 · see citing works

Pituitary adenylate cyclase-activating polypeptide protects against β-amyloid toxicity

Han, P., Tang, Z., Yin, J., Maalouf, M., Beach, T. G., Reiman, E. M., & Shi, J. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.022 · Cited by 110 · see citing works

Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer’s disease

Roher, A. E., Maarouf, C. L., Sue, L. I., Hu, Y., Wilson, J. R., & Beach, T. G. (2009) · Biomarkers · doi:10.3109/13547500903108423 · Cited by 109 · see citing works

Alterations in immunological and neurological gene expression patterns in Alzheimer's disease tissues

Weeraratna, A. T., Kalehua, A. N., DeLeon, I., Bertak, D., Maher, G., Wade, M. S., Lustig, A., Becker, K. G., Wood, W. W., Walker, D. G., et al. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.10.028 · Cited by 109 · see citing works

Weight loss, nutritional status and physical activity in patients with Alzheimer?s Disease

Wang, P., Yang, C.-L., Lin, K.-N., et al. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0316-4 · Cited by 105 · see citing works

Expression Profiles of Cytokines in the Brains of Alzheimer's Disease (AD) Patients Compared to the Brains of Non-Demented Patients with and without Increasing AD Pathology

Morimoto, K., Horio, J., Satoh, H., Sue, L. I., Beach, T. G., Arita, S., Tooyama, I., & Konishi, Y. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101815 · Cited by 104 · see citing works

Comprehensive Search for Alzheimer Disease Susceptibility Loci in the APOE Region

Jun, G., Vardarajan, B. N., Buros, J. L., Yu, C., Hawk, M., Dombroski, B. A., Crane, P. K., Larson, E. B., Mayeux, R. P., Haines, J. L., et al. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.2052 · Cited by 103 · see citing works

Aggregation State‐Dependent Activation of the Classical Complement Pathway by the Amyloid β Peptide

Webster, S. D., Bradt, B. M., Rogers, J., & Cooper, N. R. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010388.x · Cited by 103 · see citing works

Marked microglial reaction in normal aging human substantia nigra: correlation with extraneuronal neuromelanin pigment deposits

Beach, T. G., Sue, L. I., Walker, D. G., Lue, L. F., Connor, D. J., Caviness, J. N., Sabbagh, M. N., & Adler, C. H. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0250-5 · Cited by 101 · see citing works

TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologies

Arnold, S. J., Dugger, B. N., & Beach, T. G. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1110-0 · Cited by 101 · see citing works

Diagnosis of Prostate Cancer Using Differentially Expressed Genes in Stroma

Jia, Z., Wang, Y., Sawyers, A., Yao, H., Rahmatpanah, F. B., Xia, X.-Q., Xu, Q., Pio, R., Turan, T., Koziol, J. A., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2585 · Cited by 99 · see citing works

Nitric oxide (NO) is involved in increased cerebral cortical blood flow following stimulation of the nucleus basalis of Meynert in anesthetized rats

Adachi, T., Inanami, O., & Sato, A. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90552-i · Cited by 98 · see citing works

Identification of Tumor-Related Proteins by Proteomic Analysis of Cerebrospinal Fluid from Patients with Primary Brain Tumors

Zheng, P., Luider, T. M., Pieters, R., Avezaat, C. J. J., van den Bent, M. J., Smitt, P. A. E. S., & Kros, J. M. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.8.855 · Cited by 97 · see citing works

High stability of mRNAs postmortem and protocols for their assessment by RT-PCR

Yasojima, K., McGeer, E. G., & McGeer, P. L. (2001) · Brain Research Protocols · doi:10.1016/s1385-299x(01)00119-2 · Cited by 97 · see citing works

Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers

van Blitterswijk, M., Mullen, B., Heckman, M. G., Baker, M., DeJesus‐Hernandez, M., Brown, P. H., Murray, M. E., Hsiung, G. R., Stewart, H. G., Karydas, A. M., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.04.016 · Cited by 97 · see citing works

Identification of post‐mortem cerebrospinal fluid proteins as potential biomarkers of ischemia and neurodegeneration

Lescuyer, P., Allard, L., Zimmermann‐Ivol, C. G., Burgess, J., Frutiger, S., Burkhard, P. R., Sanchez, J., & Hochstrasser, D. F. (2004) · PROTEOMICS · doi:10.1002/pmic.200300822 · Cited by 96 · see citing works

Essential tremor is not associated with cerebellar Purkinje cell loss

Symanski, C. A., Shill, H. A., Dugger, B. N., et al. (2014) · Movement Disorders · doi:10.1002/mds.25845 · Cited by 95 · see citing works

Synaptophysin gene expression in human brain: A quantitative in situ hybridization and immunocytochemical study

Eastwood, S. L., Burnet, P. W. J., McDonald, B., Clinton, J., & Harrison, P. J. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90292-5 · Cited by 95 · see citing works

Relation of Coronary Atherosclerosis and Apolipoprotein E Genotypes in Alzheimer Patients

Kosunen, O., Talasniemi, S., Lehtovirta, M., Heinonen, O., Helisalmi, S., Mannermaa, A., Paljärvi, L., Ryynänen, M., Riekkinen, P. J., & Soininen, H. (1995) · Stroke · doi:10.1161/01.str.26.5.743 · Cited by 95 · see citing works

Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer’s disease

Potter, P. E., Rauschkolb, P. K., Pandya, Y., Sue, L. I., Sabbagh, M. N., Walker, D. G., & Beach, T. G. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0831-1 · Cited by 94 · see citing works

Impact of Thawing on RNA Integrity and Gene Expression Analysis in Fresh Frozen Tissue

Botling, J., Edlund, K., Segersten, U., Tahmasebpoor, S., Engström, M., Sundström, M., Malmström, P., & Micke, P. (2009) · Diagnostic Molecular Pathology · doi:10.1097/pdm.0b013e3181857e92 · Cited by 93 · see citing works

Huntington's disease

Gusella, J. F., & MacDonald, M. E. (1995) · Seminars in Cell Biology · doi:10.1016/1043-4682(95)90011-x · Cited by 93 · see citing works

In vitro high affinity α‐synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brain1

Ye, L., Velasco, A. L., Fraser, G. M., Beach, T. G., Sue, L. I., Osredkar, T., Libri, V., Spillantini, M. G., Goedert, M., & Lockhart, A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05245.x · Cited by 92 · see citing works

Gene Expression Profiles in Parkinson Disease Prefrontal Cortex Implicate FOXO1 and Genes under Its Transcriptional Regulation

Dumitriu, A., Latourelle, J. C., Hadzi, T. C., Pankratz, N., Garza, D., Miller, J. P., Vance, J. M., Foroud, T., Beach, T. G., & Myers, R. H. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002794 · Cited by 91 · see citing works

Alzheimer's disease: Mismatch between amyloid plaques and neuritic plaques

Braak, H., Braak, E., Ohm, T. G., & Böhl, J. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90479-5 · Cited by 90 · see citing works

Co-morbidity associated with dementia

Sanderson, M., Wang, J., Davis, D. R., Lane, M. J., Cornman, C. B., & Fadden, M. K. (2002) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750201700210 · Cited by 89 · see citing works

Evaluating RNA status for RT-PCR in extracts of postmortem human brain tissue

Miller, C. L., Diglisic, S., Leister, F. J., Webster, M. J., & Yolken, R. H. (2004) · BioTechniques · doi:10.2144/04364st03 · Cited by 89 · see citing works

Hippocampal Sclerosis Dementia with Tauopathy

Beach, T. G., Sue, L. I., Scott, S., Layne, K. J., Newell, A., Walker, D. G., Baker, M., Sahara, N., Yen, S.-H. C., Hutton, M. L., et al. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00027.x · Cited by 89 · see citing works

Cardiovascular Disease Risk Factors and Cognitive Impairment

Nash, D. T., & Fillit, H. M. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.031 · Cited by 88 · see citing works

Perfusion-fixation of the human brain for immunohistochemistry: comparison with immersion-fixation

Beach, T. G., Tago, H., Nagai, T., Kimurâ, H., McGeer, P. L., & McGeer, E. G. (1987) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(87)80001-8 · Cited by 87 · see citing works

Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases

Walker, D. G., & Lue, L.-F. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20484 · Cited by 87 · see citing works

Oligomerization and fibril assembly of the amyloid-β protein

Roher, A. E., Baudry, J. Y., Chaney, M. O., Kuo, Y., Stine, W. B., & Emmerling, M. R. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00030-2 · Cited by 87 · see citing works

Biobanking of Human Pancreas Cancer Tissue: Impact of Ex-Vivo Procurement Times on RNA Quality

Rudloff, U., Bhanot, U. K., Gerald, W. L., Klimstra, D. S., Jarnagin, W. R., Brennan, M. F., & Allen, P. J. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-0959-6 · Cited by 86 · see citing works

Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders

Palmqvist, S., Janelidze, S., Quiroz, Y. T., Zetterberg, H., Lopera, F., Stomrud, E., Su, Y., Chen, Y., Serrano, G. E., Leuzy, A., et al. (2020) · JAMA · doi:10.1001/jama.2020.12134 · Cited by 1,603 · see citing works

Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation

Johnson, E. C. B., Dammer, E. B., Duong, D. M., Ping, L., Zhou, M., Yin, L., Higginbotham, L. A., Guajardo, A., White, B., Troncoso, J. C., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0815-6 · Cited by 1,001 · see citing works

Diverse Brain Myeloid Expression Profiles Reveal Distinct Microglial Activation States and Aspects of Alzheimer’s Disease Not Evident in Mouse Models

Friedman, B. A., Srinivasan, K., Ayalon, G., Meilandt, W. J., Lin, H., Huntley, M. A., Cao, Y., Lee, S.-H., Haddick, P. C. G., Ngu, H., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.066 · Cited by 662 · see citing works

Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer’s Disease Progression

Bai, B., Wang, X., Li, Y., Chen, P.-C., Yu, K., Dey, K. K., Yarbro, J. M., Han, X., Lutz, B. M., Rao, S., et al. (2020) · Neuron · doi:10.1016/j.neuron.2019.12.015 · Cited by 632 · see citing works

Alzheimer’s Patient Microglia Exhibit Enhanced Aging and Unique Transcriptional Activation

Srinivasan, K., Friedman, B. A., Etxeberria, A., Huntley, M. A., van der Brug, M. P., Foreman, O., Paw, J. S., Modrusan, Z., Beach, T. G., Serrano, G. E., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107843 · Cited by 427 · see citing works

Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads

Salvadó, G., Ossenkoppele, R., Ashton, N. J., Beach, T. G., Serrano, G. E., Reiman, E. M., Zetterberg, H., Mattsson‐Carlgren, N., Janelidze, S., Blennow, K., et al. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202217123 · Cited by 205 · see citing works

Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age

Wingo, A. P., Dammer, E. B., Breen, M. S., Logsdon, B. A., Duong, D. M., Troncosco, J. C., Thambisetty, M., Beach, T. G., Serrano, G. E., Reiman, E. M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09613-z · Cited by 211 · see citing works

Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer’s disease

Wang, H., Dey, K. K., Chen, P.-C., Li, Y., Niu, M., Cho, J.-H., Wang, X., Bai, B., Jiao, Y., Chepyala, S. R., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00384-6 · Cited by 210 · see citing works

Lack of Widespread BBB Disruption in Alzheimer’s Disease Models: Focus on Therapeutic Antibodies

Bien-Ly, N., Boswell, C. A., Jeet, S., Beach, T. G., Hoyte, K., Luk, W., Shihadeh, V., Ulufatu, S., Foreman, O., Lu, Y., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.09.036 · Cited by 198 · see citing works

Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease

Cicognola, C., Brinkmalm, G., Wahlgren, J., Portelius, E., Gobom, J., Cullen, N. C., Hansson, O., Parnetti, L., Constantinescu, R., Wildsmith, K., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1948-2 · Cited by 168 · see citing works

Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and Cognition

Filon, J. R., Intorcia, A. J., Sue, L. I., Vazquez Arreola, E., Wilson, J., Davis, K. J., Sabbagh, M. N., Belden, C. M., Caselli, R. J., Adler, C. H., et al. (2016) · Journal of Neuropathology &amp; Experimental Neurology · doi:10.1093/jnen/nlw047 · Cited by 143 · see citing works

Deep undepleted human serum proteome profiling toward biomarker discovery for Alzheimer’s disease

Dey, K. K., Wang, H., Niu, M., Bai, B., Wang, X., Li, Y., Cho, J.-H., Tan, H., Mishra, A., High, A. A., et al. (2019) · Clinical Proteomics · doi:10.1186/s12014-019-9237-1 · Cited by 135 · see citing works

Patterns of Expression of Purinergic Receptor P2RY12, a Putative Marker for Non-Activated Microglia, in Aged and Alzheimer’s Disease Brains

Walker, D. G., Tang, T. M., Mendsaikhan, A., Tooyama, I., Serrano, G. E., Sue, L. I., Beach, T. G., & Lue, L.-F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020678 · Cited by 128 · see citing works

Genetic control of the human brain proteome

Robins, C., Wingo, A. P., Fan, W., Duong, D. M., Meigs, J., Gerasimov, E. S., Dammer, E. B., Cutler, D. J., Jager, P. L. D., Bennett, D. A., et al. (2019) · doi:10.1101/816652 · Cited by 104 · see citing works

T cell infiltration in both human multiple system atrophy and a novel mouse model of the disease

Williams, G. P., Marmion, D. J., Schonhoff, A. M., Jurkuvenaite, A., Won, W.-J., Standaert, D. G., Kordower, J. H., & Harms, A. S. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02126-w · Cited by 102 · see citing works

Sex differences in brain protein expression and disease

Wingo, A. P., Liu, Y., Gerasimov, E. S., Vattathil, S. M., Liu, J., Cutler, D. J., Epstein, M. P., Blokland, G. A. M., Thambisetty, M., Troncoso, J. C., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02509-y · Cited by 94 · see citing works

Effects of APOE Genotype on Brain Proteomic Network and Cell Type Changes in Alzheimer's Disease

Dai, J., Johnson, E. C. B., Dammer, E. B., Duong, D. M., Gearing, M., Lah, J. J., Levey, A. I., Wingo, T. S., & Seyfried, N. T. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00454 · Cited by 62 · see citing works

Characterization of lysosomal proteins Progranulin and Prosaposin and their interactions in Alzheimer’s disease and aged brains: increased levels correlate with neuropathology

Mendsaikhan, A., Tooyama, I., Bellier, J.-P., Serrano, G. E., Sue, L. I., Lue, L.-F., Beach, T. G., & Walker, D. G. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0862-8 · Cited by 57 · see citing works

MicroRNA-101 Modulates Autophagy and Oligodendroglial Alpha-Synuclein Accumulation in Multiple System Atrophy

Valera, E., Spencer, B., Mott, J., Trejo, M., Adame, A., Mante, M., Rockenstein, E., Troncoso, J. C., Beach, T. G., Masliah, E., et al. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00329 · Cited by 55 · see citing works

Calpain-mediated tau fragmentation is altered in Alzheimer’s disease progression

Chen, H.-H., Liu, P., Auger, P., Lee, S.-H., Adolfsson, O., Rey-Bellet, L., Lafrance-Vanasse, J., Friedman, B. A., Pihlgren, M., Muhs, A., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-35130-y · Cited by 51 · see citing works

Loss of primary cilia and dopaminergic neuroprotection in pathogenic LRRK2-driven and idiopathic Parkinson’s disease

Khan, S. S., Jaimon, E., Lin, Y.-E., Nikoloff, J., Tonelli, F., Alessi, D. R., & Pfeffer, S. R. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2402206121 · Cited by 61 · see citing works

Quantitative proteomics of synaptosome <i>S</i>‐nitrosylation in Alzheimer’s disease

Wijasa, T. S., Sylvester, M., Brocke‐Ahmadinejad, N., Schwartz, S., Santarelli, F., Gieselmann, V., Klockgether, T., Brosseron, F., & Heneka, M. T. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14870 · Cited by 41 · see citing works

Cortical phosphorylated α‐Synuclein levels correlate with brain wave spectra in Parkinson's disease

Caviness, J. N., Lue, L., Hentz, J. G., Schmitz, C. T., Adler, C. H., Shill, H. A., Sabbagh, M. N., Beach, T. G., & Walker, D. G. (2016) · Movement Disorders · doi:10.1002/mds.26621 · Cited by 37 · see citing works

Targeted metabolomic analysis in Parkinson’s disease brain frontal cortex and putamen with relation to cognitive impairment

Kalecký, K., & Bottiglieri, T. (2023) · npj Parkinson's Disease · doi:10.1038/s41531-023-00531-y · Cited by 32 · see citing works

Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not α-synuclein pathology

Walker, D. G., Lue, L.-F., Tang, T. M., Adler, C. H., Caviness, J. N., Sabbagh, M. N., Serrano, G. E., Sue, L. I., & Beach, T. G. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.03.007 · Cited by 33 · see citing works

Bridging the gap: Multi‐omics profiling of brain tissue in Alzheimer's disease and older controls in multi‐ethnic populations

Reddy, J. S., Heath, L., Linden, A. V., Allen, M., Lopes, K. D. P., Seifar, F., Wang, E., Ma, Y., Poehlman, W. L., Quicksall, Z. S., et al. (2024) · Alzheimer's &amp; Dementia · doi:10.1002/alz.14208 · Cited by 29 · see citing works

Vascular Lesions, <i>APOE</i> ε4, and Tau Pathology in Alzheimer Disease

Nichols, J. B., Malek-Ahmadi, M., Tariot, P. N., Serrano, G. E., Sue, L. I., & Beach, T. G. (2021) · Journal of Neuropathology &amp; Experimental Neurology · doi:10.1093/jnen/nlaa160 · Cited by 22 · see citing works

Study on pathological diagnosis of pathological changes of 457 patients with atypical squamous cells

Hao-hu, C. (2008) · Zhongguo redai yixue

Conformity or Counter-Conformity Behavior? The Effect of Prior Charitable Giving in Donation-Based Crowdfunding

Wu, Y., Xie, X., & Zheng, K. (2020) · International Journal of Business and Social Research · doi:10.18533/ijbsr.v10i5.1341

Review of clinical and pathological characteristics in 68 children with henoch-schsnlein purpura nephritics

Pei-ling, B. (2009) · Medical Information(Medicine & Surgery)

Giving from a distance: Putting the charitable organization at the center of the donation appeal

Ein‐Gar, D., & Levontin, L. (2012) · Journal of Consumer Psychology · doi:10.1016/j.jcps.2012.09.002 · Cited by 181 · see citing works

Pathological gambling and substance misuse: a review of the literature.

Spunt, B., Dupont, I., Lesieur, H., Liberty, H. J., & Hunt, D. E. (1998) · Substance Use & Misuse · doi:10.3109/10826089809059340 · Cited by 85 · see citing works